Cerenome (PSTV) Invested Capital (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Invested Capital of $667000.0 for Q1 2026, down 11.07% quarter-over-quarter from $750000.0 in Q4 2025.
Cerenome (PSTV) Invested Capital (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Invested Capital for 17 consecutive years, with $667000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $667000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 85.65% YoY), while the FY2025 annual figure was $750000.0, down 77.22% from the prior year.
- Invested Capital eased to $667000.0 in Q1 2026 per PSTV's latest filing, from $750000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $5.1 million in Q1 2023 and bottomed at $667000.0 in Q1 2026.
- Historically, Invested Capital has averaged $2.8 million across 5 years, with a median of $3.3 million in 2024.
- Annual changes were most pronounced in 2023 — Invested Capital jumped 214.49% — and 2025, when it slumped 77.22%.
- Plus Therapeutics' Invested Capital stood at $1.6 million in 2022, then surged by 147.26% to $4.0 million in 2023, then fell by 17.2% to $3.3 million in 2024, then plunged by 77.22% to $750000.0 in 2025, then dropped by 11.07% to $667000.0 in 2026.
- Business Quant data shows PSTV's Invested Capital at $667000.0 in Q1 2026, $750000.0 in Q4 2025, and $3.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 3.29 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | 4.35 Mn |
| Jun 30, 2023 | 4.71 Mn |
| Mar 31, 2023 | 5.06 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 6.75 Mn |
| Jun 30, 2021 | 6.62 Mn |
| Mar 31, 2021 | 6.49 Mn |
| Dec 31, 2020 | 10,000.00 |
| Sep 30, 2020 | 6.18 Mn |